Cargando...
Novel Antigen Targets for Immunotherapy of Acute Myeloid Leukemia
Acute myeloid leukemia (AML) was the first malignancy for which immunotherapy, in the form of allogeneic hematopoietic stem cell transplantation (allo-HSCT), was integrated into the standard of care. Allo-HSCT however is an imperfect therapy associated with significant morbidity and mortality while...
Guardado en:
| Publicado en: | Curr Drug Targets |
|---|---|
| Autores principales: | , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
2017
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6321986/ https://ncbi.nlm.nih.gov/pubmed/25706110 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2174/1389450116666150223120005 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|